Kaempferol Protects Cell Damage in In Vitro Ischemia Reperfusion Model in Rat Neuronal PC12 Cells
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 2461079
Abstract
Ischemic cerebral stroke is a severe neurodegenerative disease with high mortality. Ischemia and reperfusion injury plays a fundamental role in ischemic cerebral stroke. To date, the strategy for ischemic cerebral stroke treatment is limited. In the present study, we aimed to investigate the effect of kaempferol (KFL), a natural flavonol, on cell injury induced by oxygen and glucose deprivation (OGD) and reoxygenation (OGD‐reoxygenation) in PC12 cells. We found that KFL inhibited OGD‐induced decrease of cell viability and the increase of lactate dehydrogenase (LDH) release. OGD‐induced activation of mitochondrial dysfunction, mitochondrial apoptotic pathway, and apoptosis was inhibited by KFL. KFL also reduced OGD‐induced oxidative stress in PC12 cells. P66shc expression and acetylation were increased by OGD and KFL inhibited these changes. Upregulation of P66shc suppressed KFL‐induced decrease of apoptosis, the decrease of LDH release, and the increase of cell viability. Furthermore, KFL inhibited OGD‐induced decrease of sirtuin 1 (SIRT1) expression and downregulation of SIRT1 blocked KFL‐induced decrease of apoptosis, the decrease of LDH release, and the increase of cell viability. In summary, we identified that KFL exhibited a beneficial effect against OGD‐induced cytotoxicity in an ischemia/reperfusion injury cell model. The findings suggest that KFL may be a promising choice for the intervention of ischemic stroke and highlighted the SIRT1/P66shc signaling.Keywords
This publication has 32 references indexed in Scilit:
- Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and Neuroinflammation by Inhibiting the Activation of NF-κB and STAT3 in Transient Focal StrokePLOS ONE, 2013
- Antioxidant Phenolic Compounds from Pu-erh TeaMolecules, 2012
- trans-Resveratrol Protects Ischemic PC12 Cells by Inhibiting the Hypoxia Associated Transcription Factors and Increasing the Levels of Antioxidant Defense EnzymesACS Chemical Neuroscience, 2012
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Protective Effects of Kaempferol (3,4′,5,7-tetrahydroxyflavone) against Amyloid Beta Peptide (Aβ)-Induced Neurotoxicity in ICR MiceBioscience, Biotechnology, and Biochemistry, 2010
- Mitochondria, oxidative metabolism and cell death in strokeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorStroke, 2009
- PGC-1α: a key regulator of energy metabolismAdvances in Physiology Education, 2006
- Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia–ischaemiaJournal of Neurochemistry, 2006
- Thrombolysis for acute ischaemic stroke2003